ADVERTISEMENT
Micrograph of kidney tissue from a mouse
Vesicles from Young Mice Alleviate Signs of Aging in Older Animals
Mice that received the stem cell–derived treatment were less frail compared with controls, a study reports.
Vesicles from Young Mice Alleviate Signs of Aging in Older Animals
Vesicles from Young Mice Alleviate Signs of Aging in Older Animals

Mice that received the stem cell–derived treatment were less frail compared with controls, a study reports.

Mice that received the stem cell–derived treatment were less frail compared with controls, a study reports.

stem cell therapies
Susan Solomon looking into the camera
Lawyer Turned Stem Cell Advocate Susan Solomon Dies at 71
Lisa Winter | Sep 27, 2022 | 2 min read
Her passion came from her son’s struggle with type 1 diabetes and the inability to find new treatments.
Blue T cell with other blurred T cells in the background
Woman Seemingly Cured of HIV After Umbilical Cord Transplant
Natalia Mesa, PhD | Feb 16, 2022 | 3 min read
Umbilical cord blood may be a good alternative to bone marrow transplants for treating HIV in patients with HIV and cancer.
Harnessing Stem Cells to Model Neurological Disorders
The Scientist Creative Services Team | 2 min read
An artistic rendering of blue neurons against a white background
Participant’s Diagnosis Halts Gene Therapy Clinical Trial
Amanda Heidt | Aug 12, 2021 | 3 min read
The FDA pauses the research program on a lentivirus-based treatment for a rare neurological condition after a patient developed a bone marrow disorder that could presage leukemia.
illustration of different cells types in retina
Cones Derived from Human Stem Cells Help Mice See: Study
Marcus A. Banks | Apr 23, 2021 | 3 min read
Researchers insert functioning cone photoreceptors into the retinas of mice with advanced eye disease, improving their vision.
a pipette drops a dollar sign into a test tube
Voters in California Extend Life of Stem Cell Funding Agency
Katarina Zimmer | Nov 13, 2020 | 2 min read
The state will take on additional debt to finance CIRM, which will now continue to fund stem cell research, training, and clinical trials.
a pipette dropping clear liquid into a well plate
California Voters to Decide Future of Stem Cell Funding Agency
Katarina Zimmer | Oct 24, 2020 | 6 min read
If approved, Proposition 14 would authorize the state to sell $5.5 billion in bonds to extend the life of CIRM, which funds stem cell research. The ballot measure has its critics.
Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
Ruth Williams | Apr 9, 2020 | 5 min read
As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.
cardiac stem cell therapy immune system macrophage
Activation of the Immune System Underlies Cardiac Cell Therapies
Ruth Williams | Nov 27, 2019 | 4 min read
A study in mice reveals that stem cell transplants, currently in clinical trials, may not actually require the cells.
Infographic: Light in the Dark
Nicoletta Lanese | Oct 1, 2019 | 1 min read
A new tool helps stem cells integrate with host neural circuitry after implantation in mice.
CIRM California Institute for Regenerative Medicine funding running out not taking grant applications stem cell agency granting
Stem Cell Funding Agency CIRM Is Nearly Out of Funds
Chia-Yi Hou | Jul 8, 2019 | 3 min read
The California Institute for Regenerative Medicine has been funding research since it formed in 2004, giving out nearly $3 billion in grants to date.
natural killer cells nk cell therapy product immunotherapy clinical trial
Clinical Trial Underway for a Natural Killer Cell Therapy
Chia-Yi Hou | May 7, 2019 | 3 min read
The cells, derived from induced pluripotent stem cells, are in testing as an immunotherapy for cancer patients with solid tumors.
Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Jef Akst | Apr 30, 2019 | 2 min read
Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.
Japan Approves iPS Cell Therapy Trial for Spinal Cord Injury
Catherine Offord | Feb 18, 2019 | 1 min read
The treatment will be tested in a handful of patients who suffered nerve damage in sports or traffic accidents.
Call to Stop Using the Term “Mesenchymal Stem Cell”
Abby Olena, PhD | Sep 26, 2018 | 4 min read
Critics say the misleading term actually refers to a heterogeneous population of cells, including possible tissue-specific progenitor cells and nonstem cells all lumped together.
Natural Killer Cells Prove Effective as a CAR Therapy in Mice
Katarina Zimmer | Jul 6, 2018 | 4 min read
Stem-cell–derived natural killer cells engineered in a similar way to CAR-T cells may pave the way to “off the shelf” cancer therapies that aren’t patient-specific.
Dopamine Neuron Implants Ease Parkinson’s Symptoms in Monkeys
Sukanya Charuchandra | Jun 20, 2018 | 3 min read
The stem cell–derived transplants were stable for 24 months and led to wide-ranging behavioral improvements in the monkeys.  
FDA Seeks to Block Two Unregulated Stem Cell Clinics
Jim Daley | May 11, 2018 | 2 min read
Two patients became legally blind after receiving treatments at the facilities.
Can Young Stem Cells Make Older People Stronger?
Shawna Williams | Dec 11, 2017 | 4 min read
Small trials using younger donors and elderly recipients hint that mesenchymal stem cell transfers might reduce frailty. 
ADVERTISEMENT